SG
Sandipkumar Gopalbhai Patel
About Sandipkumar Gopalbhai Patel
Data last updated:
Sandipkumar Gopalbhai Patel is a Director at Soxa Formulations And Research Private Limited (since 2016), Director at Nephrine Pharmaceuticals Private Limited (since 2026) and Partner at Gramino Healthcare Llp (since 2024). The companies operate in Healthcare and Pharma. The largest current company by reported revenue is Soxa Formulations And Research Private Limited at ₹11.33 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jul 2016 | 2015 | ₹11.33 Cr (FY 2025) | Active | |
| Director | 23 Feb 2026 | 2026 | Active | ||
| Partner | 07 Jun 2024 | 2024 | Active |
Board colleagues of Sandipkumar Gopalbhai Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bharatkumar Haribhai Patel | 07568280 | Soxa Formulations And Research Private Limited | Director |
| Brijeshkumar Keshabhai Patel | 07130188 | Soxa Formulations And Research Private Limited | Director |
| Vimalkumar Manibhai Patel | 07563986 | Soxa Formulations And Research Private Limited | Director |
| Piyushkumar Kantibhai Patel | 10517515 | Nephrine Pharmaceuticals Private Limited , Gramino Healthcare Llp | Director |
| Chintan Bharatbhai Patel | 10660110 | Gramino Healthcare Llp | Designated Partner |
| Chiragkumar Sureshbhai Patel | 10660109 | Gramino Healthcare Llp | Designated Partner |
| Tusharkumar Mukeshbhai Patel | 10660111 | Gramino Healthcare Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandipkumar Gopalbhai Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandipkumar Gopalbhai Patel
Sandipkumar Gopalbhai Patel currently holds 3 directorships: Soxa Formulations And Research Private Limited (Director, since 25 Jul 2016, revenue ₹11.33 Cr (FY 2025)); Nephrine Pharmaceuticals Private Limited (Director, since 23 Feb 2026); Gramino Healthcare Llp (Partner, since 07 Jun 2024).
Sandipkumar Gopalbhai Patel was first appointed on 25 Jul 2016 as Director at Soxa Formulations And Research Private Limited. The most recent appointment on record is 23 Feb 2026 at Nephrine Pharmaceuticals Private Limited.
The current boards of Sandipkumar Gopalbhai Patel's companies include Bharatkumar Haribhai Patel (Soxa Formulations And Research Private Limited), Brijeshkumar Keshabhai Patel (Soxa Formulations And Research Private Limited), Vimalkumar Manibhai Patel (Soxa Formulations And Research Private Limited), Piyushkumar Kantibhai Patel (Nephrine Pharmaceuticals Private Limited), Chintan Bharatbhai Patel (Gramino Healthcare Llp), Chiragkumar Sureshbhai Patel (Gramino Healthcare Llp), among others.